Внутренние болезни
1007 статей · 31 журналов
Журналы подкатегории (31)
- Kidney Medicine · Elsevier (97)
- European Journal of Internal Medicine · Elsevier (94)
- Canadian Journal of Diabetes · Elsevier (92)
- International Journal of Cardiology Cardiovascular Risk and Prevention · Elsevier (89)
- JHEP Reports · Elsevier (88)
- Diabetes Research and Clinical Practice · Elsevier (77)
- Journal of Diabetes Investigation · Wiley (75)
- Internal Medicine Journal · Wiley (74)
- Médecine des Maladies Métaboliques · Elsevier (66)
- La Revue de Médecine Interne · Elsevier (58)
- Atherosclerosis Plus · Elsevier (42)
- The Lancet Diabetes & Endocrinology · Elsevier (42)
- American Journal of Medicine Open · Elsevier (31)
- Journal of Internal Medicine · Wiley (24)
- Journal of General and Family Medicine · Wiley (16)
- Journal of Diabetes and its Complications · Elsevier (13)
- Diabetes & Metabolic Syndrome: Clinical Research & Reviews · Elsevier (11)
- Nutrition Clinique et Métabolisme · Elsevier (10)
- Journal of Human Hypertension · Springer Nature (8)
- Current Diabetes Reports · Springer Nature (0)
- Current Hypertension Reports · Springer Nature (0)
- Current Obesity Reports · Springer Nature (0)
- Diabetes Therapy · Springer Nature (0)
- Diabetologia · Springer Nature (0)
- Diabetology International · Springer Nature (0)
- Internal and Emergency Medicine · Springer Nature (0)
- International Journal of Diabetes in Developing Countries · Springer Nature (0)
- Journal of General Internal Medicine · Springer Nature (0)
- Journal of Rare Diseases · Springer Nature (0)
- Journal of Ultrasound · Springer Nature (0)
- Medizinische Klinik - Intensivmedizin und Notfallmedizin · Springer Nature (0)
- The development of obesity pharmacotherapy: from early challenges and setbacks to recognition by WHO
- Iodine in the UK: the end of an “accidental public health triumph”
- Oral small-molecule GLP-1 receptor agonist for obesity in people from Japan
- Efficacy and safety of oral orforglipron in Japanese participants with obesity disease (ATTAIN-J): a double-blind, randomised, placebo-controlled, parallel-group, phase 3 trial
- Who should prescribe obesity management medications? An IFSO position statement
- Clinical and metabolic subtypes of recent-onset adult type 1 diabetes: a prospective cohort study
- Safeguarding paediatric metabolic health
- The glucagon renaissance in obesity therapeutics
- What Mauritius teaches us about diabetes surveillance
- Petrelintide and the evolving role of amylin agonism in obesity
- Precision medicine in type 2 diabetes: should clustering be used?
- Bone mineral density as a surrogate endpoint in osteoporosis trials
- Bone mineral density as a surrogate endpoint in osteoporosis trials – Author's reply
- Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial
- Trends in prevalence of type 2 diabetes and intermediate hyperglycaemia in Mauritius from 1987 to 2021 based on results from the oral glucose tolerance test: a repeated cross-sectional study
- Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case–control study
- Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial
- Hypoparathyroidism: translating science from the laboratory to the clinic
- From adiposity to multisystem morbidity: the case for weight loss as disease modification
- Disease modification outcomes in type 2 diabetes: a modified Delphi
- Presentation, management, and outcomes of ectopic Cushing syndrome: an international, multicentre, retrospective, cohort study
- Signals: The Inside Story of Our Hormones, Saira Hameed. Faber & Faber (2026), 326, £20·00, ISBN: 9780571389773
- Diagnosing diabetes: the earlier the better
- Efficacy and safety of co-administered cagrilintide–semaglutide (CagriSema) 1·7 mg each and 1·0 mg each in adults with overweight or obesity (REDEFINE 9): a multicentre, randomised, double-blind within-dose-level, placebo-controlled, parallel-group, phase 3b trial
- The right dose, not the highest dose: rethinking obesity pharmacotherapy
- L’éditorial de la vice-présidente de la SFNCM
- Prise de poids induite par les antipsychotiques et obésité chez les personnes atteintes de troubles psychiques sévères : analogues du GLP-1 et rôles des infirmiers en pratique avancée
- L’enfant en nutrition parentérale : de l’hôpital au domicile et de l’enfance à l’âge adulte
- Microbial metabolites for gut barrier restoration: Insight from mechanisms, interactions, and therapeutic potential
- Fermentation in the colon: A natural tool for nutrient efficiency and metabolic balance